Mount Sinai shows the potential link between Parkinson's disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson's...
The post Anti-TNFα therapy may help reduce risk of developing Parkinson’s disease appeared first on European Pharmaceutical Review.